Immunohistochemical studies have demonstrated that the elevated cytoplasmic expression of SIRT2 in benign pancreatic tissue correlates with a reduced disease-free survival, suggesting that SIRT2’s role in pancreatic cancer may extend beyond tumor cells themselves by influencing the surrounding microenvironment. Here, SIRT2 is linked to pancreatic neoplasm.